Mast Cell Protease 8 (MCP-8) inhibitors, as per current scientific understanding, are not exclusively available. However, the compounds listed here demonstrate potential for indirectly inhibiting or influencing MCP-8 activity by targeting related serine proteases or pathways within mast cells. Serine proteases, a category to which MCP-8 belongs, are crucial in various physiological processes including digestion, immune response, and blood coagulation. The inhibitors like Gabexate Mesilate, Nafamostat Mesilate, and Camostat Mesilate, are broad-spectrum and target enzymes like trypsin, kallikrein, and plasmin. These enzymes share functional similarities with MCP-8, suggesting that their inhibition might have a downstream effect on MCP-8 activities.
The use of these inhibitors provides insight into the complexity of protease regulation within biological systems, particularly in mast cells. Mast cells, known for their role in allergy and inflammation, contain various serine proteases, including MCP-8. By inhibiting enzymes that are part of the same family or pathway, one can indirectly influence the activity of MCP-8. This approach is often necessary in cases where direct inhibitors are not available. For instance, Aprotinin and Leupeptin Hemisulfate demonstrate this indirect inhibition approach by targeting related proteases. Other compounds like E-64 and Pepstatin A, though not serine protease inhibitors, contribute to the broader protease inhibition landscape, potentially affecting MCP-8 activity in an indirect manner. In conclusion, while direct MCP-8 inhibitors are not currently identified, the chemicals listed offer a strategic approach to modulate related protease activities and pathways. The understanding of these compounds and their effects on serine proteases aids in exploring potential avenues for influencing MCP-8 activity, underscoring the intricate network of proteases and their inhibitors in biological systems. This knowledge is crucial for advancing research in areas related to mast cell physiology and associated disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
A synthetic serine protease inhibitor, Gabexate Mesilate targets various proteases including trypsin, kallikrein, and plasmin, potentially affecting MCP-8 related pathways by reducing proteolytic activities in mast cells. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Nafamostat Mesilate is a broad-spectrum serine protease inhibitor, known for inhibiting factors like thrombin and trypsin, which could indirectly affect MCP-8 activity by modulating related protease activity in mast cells. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
This serine protease inhibitor, Camostat Mesilate, specifically inhibits trypsin, kallikrein, and plasmin, which may contribute to the regulation of proteases in mast cells, thereby indirectly influencing MCP-8. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin, a polypeptide inhibitor, predominantly inhibits trypsin, chymotrypsin, and plasmin, and could indirectly impact MCP-8 activity through its effect on related serine proteases in mast cells. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Acting as an inhibitor for several proteases like trypsin, plasmin, and papain, Leupeptin Hemisulfate may have an indirect impact on MCP-8 by modulating proteolytic processes within mast cells. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a cysteine protease inhibitor, known to inhibit cathepsins B, H, and L, which could indirectly affect MCP-8 by altering protease dynamics within mast cells. | ||||||
Tranexamic acid | 1197-18-8 | sc-204921 sc-204921A | 5 g 10 g | $29.00 $50.00 | 10 | |
Tranexamic Acid, an antifibrinolytic agent, inhibits plasminogen activation and could indirectly affect MCP-8 activity by altering protease pathways in mast cells. | ||||||
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
Primarily a trypsin inhibitor, Benzamidine Hydrochloride could potentially influence MCP-8 by modulating serine protease activities in mast cells. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $156.00 $260.00 $640.00 $1186.00 $2270.00 | 3 | |
Chymostatin is a chymotrypsin inhibitor and might indirectly affect MCP-8 activity by influencing related protease functions in mast cells. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF Hydrochloride is a broad-spectrum serine protease inhibitor, potentially impacting MCP-8 by altering related protease activities in mast cells. | ||||||